ArticleScientific reports2019

Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent.

Hien Thi Thu Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.